AGP Executive Report
Last update: 5 hours agoVaccine Manufacturing: Zambia has begun building a $24.13 million cholera vaccine plant with China’s Jijia International and the Industrial Development Corporation. ZAMVAX aims to reduce reliance on imported vaccines and strengthen outbreak preparedness. Medical Technology: A 20-year-old has heard again after Zambia’s first cochlear implant activation at University Teaching Hospital, a milestone for specialist hearing care. Nuclear Energy: An IAEA review found Zambia is advancing the groundwork for a possible nuclear power programme, while identifying further priorities before the country can make an informed commitment. Digital Finance: Absa says its agency-banking pilot handled more than K300 million through over 100 agents; the bank aims to expand to 1,000 agents by year-end.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.